6505--Relyvrio
Award Notice Posted
- Solicitation number
- 36C26024F0092
- Agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Awarded
- to Amylyx Pharmaceuticals Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79723D013636C26024F0092 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a sole source contract to Amylyx Pharmaceuticals Inc. for the provision of Relyvrio, an oral treatment for amyotrophic lateral sclerosis. The contract, number 36F79723D013636C26024F0092, has an award amount of $279,718.28 and a period of performance from December 20, 2023 through March 31, 2024. Relyvrio will be provided to 26 patients in the Puget Sound VA Health Care System to help slow the progression of ALS and extend patients' life expectancy.
Notice text
See attachments for award notice and limited source justification. Awarded contract 36F79723D013636C26024F0092 to AMYLYX PHARMACEUTICALS INC for 279718.28 on 2023-12-20.
Files
| File | Type | Posted |
|---|---|---|
| Redacted JA for Relyvrio.pdf | ||
| 36F79723D0136 36C26024F0092_1.docx | DOCX document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity